24.07.2025

Interview with Vice President Maciej Grzywacki on BIZNES24 television

In the program “Spółka pod lupą” (Company under the microscope) broadcast on BIZNES24, Vice President of the Management Board Maciej Grzywacki presented the current achievements of Proacta SA and announced ambitious development plans. The conversation focused on, among other things, impressive financial results, the company's strategy in the bioinformatics sector, and future research and development projects.

116% increase in net revenue y/y

Proacta estimates that in the second quarter of 2025, it achieved PLN 2.6 million in net revenue, which represents a 116% increase year-on-year.

As Maciej Grzywacki emphasized:

“This was not a random jump. It is the result of a consistently implemented strategy that we have been working on for a year and a half.”

Strategy: AI, medicine, and bioinformatics

For over eight years, Proacta has been developing unique competencies combining technology and medicine.

The current strategy focuses on:

• creating and delivering analytical and predictive models for the medical sector
• developing its own IT products
• providing bioinformatics services to research centers and public institutions
• cooperating with universities and partners in R&D projects

Own solution: Smart LAB

The key product is the Dbam o Siebie Smart LAB platform, which enables the interpretation of blood test results.

As the Vice President pointed out:

“The platform is undergoing further development and forms the foundation of our B2B activities. We are currently implementing several pilot projects, which will soon show its real impact on the efficiency of the healthcare system.”

Plans for the future

The company is not slowing down.

“We have entered areas that are crisis-resistant. This is just the beginning,” summarized Maciej Grzywacki.

See the entire material and learn about the development directions of Proacta SA interview on our YouTube channel